LBel Supremacie Mains is a Topical Cream in the Human Otc Drug category. It is labeled and distributed by Ventura International Ltd.,. The primary component is Ensulizole; Octinoxate; Oxybenzone.
Product ID | 14783-072_f9c27f44-9167-439a-a8bf-0280eabe477e |
NDC | 14783-072 |
Product Type | Human Otc Drug |
Proprietary Name | LBel Supremacie Mains |
Generic Name | Ensulizole, Octinoxate, And Oxybenzone |
Dosage Form | Cream |
Route of Administration | TOPICAL |
Marketing Start Date | 2010-08-15 |
Marketing Category | OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL |
Application Number | part352 |
Labeler Name | VENTURA INTERNATIONAL LTD., |
Substance Name | ENSULIZOLE; OCTINOXATE; OXYBENZONE |
Active Ingredient Strength | 3 g/100mL; g/100mL; g/100mL |
NDC Exclude Flag | E |
Listing Certified Through | 2017-12-31 |
Marketing Start Date | 2010-08-15 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | OTC MONOGRAPH FINAL |
Application Number | part352 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2010-08-15 |
Marketing Category | OTC MONOGRAPH FINAL |
Application Number | part352 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2010-08-15 |
Inactivation Date | 2019-10-21 |
Ingredient | Strength |
---|---|
ENSULIZOLE | 3 g/100mL |
SPL SET ID: | 2062a8d1-de1e-468c-9105-20aa01e1150f |
Manufacturer | |
UNII |
NDC | Brand Name | Generic Name |
---|---|---|
14783-062 | LBel | Ensulizole, Octinoxate, and Oxybenzone |
14783-072 | LBel | Ensulizole, Octinoxate, and Oxybenzone |